OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS
Want to see KIDS full AI Analyst Report?
KIDS Stock Chart & Stats
$16.75
-$0.10(-0.41%)
At close: 4:00 PM EST
$16.75
-$0.10(-0.41%)
Day’s Range― - ―
52-Week Range$14.55 - $23.70
Previous CloseN/A
Volume20.12K
Average Volume (3M)196.93K
Market Cap
$370.08M
Enterprise Value$398.88M
Total Cash (Recent Filing)$60.85M
Total Debt (Recent Filing)$48.36M
Price to Earnings (P/E)―
Beta0.77
Next Earnings
Apr 30, 2026EPS Estimate
-0.46Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding25,278,788
10 Day Avg. Volume194,659
30 Day Avg. Volume196,931
Financial Highlights & Ratios
PEG Ratio-3.45
Price to Book (P/B)1.20
Price to Sales (P/S)1.76
P/FCF Ratio-26.10
Enterprise Value/Market Cap1.08
Enterprise Value/Revenue1.69
Enterprise Value/Gross Profit2.31
Enterprise Value/Ebitda-50.62
Forecast
1Y Price Target
$25.00Price Target Upside49.25% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)-1.17
Revenue Forecast (FY)$264.31M
Bulls Say, Bears Say
Bulls Say
Free Cash Flow And LiquidityCompany generated positive free cash flow and materially reduced cash burn, improving the ability to fund operations and lowering the likelihood of equity dilution.
Product Pipeline And New LaunchesAnalyst highlights a broad pipeline of new implant and bracing product launches that could expand addressable markets and drive a new product-led growth cycle.
Valuation And Market PositionShares trade at a discount to peers while the company is positioned as a clear leader in pediatric orthopedics, creating scope for valuation multiple expansion as execution continues.
Bears Say
Exposure To Oil-related FactorsExposure to oil-related factors could depress demand in certain end markets and introduce revenue volatility that weighs on results.
Profitability Execution RiskAdjusted EBITDA missed expectations and operating margins lagged, signaling execution risk around achieving sustainable profitability improvements.
Quarterly Volatility And RevisionsQuarter-to-quarter revenue swings and potential negative revisions can erode investor confidence and pressure the company’s valuation multiple.
OrthoPediatrics News
KIDS FAQ
What was OrthoPediatrics Corp’s price range in the past 12 months?
OrthoPediatrics Corp lowest stock price was $14.55 and its highest was $23.70 in the past 12 months.
What is OrthoPediatrics Corp’s market cap?
OrthoPediatrics Corp’s market cap is $370.08M.
When is OrthoPediatrics Corp’s upcoming earnings report date?
OrthoPediatrics Corp’s upcoming earnings report date is Apr 30, 2026 which is today.
How were OrthoPediatrics Corp’s earnings last quarter?
Currently, no data Available
Is OrthoPediatrics Corp overvalued?
According to Wall Street analysts OrthoPediatrics Corp’s price is currently Undervalued.
Does OrthoPediatrics Corp pay dividends?
OrthoPediatrics Corp does not currently pay dividends.
What is OrthoPediatrics Corp’s EPS estimate?
OrthoPediatrics Corp’s EPS estimate is -0.46.
How many shares outstanding does OrthoPediatrics Corp have?
OrthoPediatrics Corp has 25,278,788 shares outstanding.
What happened to OrthoPediatrics Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of OrthoPediatrics Corp?
Currently, no hedge funds are holding shares in KIDS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
OrthoPediatrics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$25.00 (49.25% Upside)
$25.00 (49.25% Upside)
Blogger Sentiment
Bullish
KIDS Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 60.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.43%
12-Months-Change
Fundamentals
Return on Equity
-11.34%
Trailing 12-Months
Asset Growth
8.14%
Trailing 12-Months
Company Description
OrthoPediatrics Corp
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
KIDS Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a broadly positive operational and financial trajectory: strong top-line growth (Q4 +17%, FY +15%), meaningful margin expansion (Q4 gross margin 73%), material adjusted EBITDA improvement, and the first quarter of positive free cash flow contributing to a major year-over-year cash usage improvement (down $26M or 63%). The company also highlighted a deep product pipeline, multiple regulatory and commercial milestones (including EU MDR approvals and FDA clears), and reiterated confident 2026 targets (revenue $262–$266M, ~$25M adjusted EBITDA, free cash flow breakeven). Offsets include continued GAAP and non-GAAP losses, elevated G&A spending, timing-related R&D variability, early-stage digital/adjacency initiatives with limited near-term revenue, and seasonal cash-flow volatility. Overall, the favorable financial inflection, product momentum, and guidance credibility outweigh the remaining execution and timing risks.View all KIDS earnings summariesKIDS Stock 12 Month Forecast
Average Price Target
$25.00
▲(49.25% Upside)
Technical Analysis
Orthofix Medical
―
Tandem Diabetes Care
―
Varex Imaging
―
Bioventus
―
Treace Medical Concepts
―
Ownership Overview
33.17% Insiders
13.41% Mutual Funds
3.20% Other Institutional Investors
42.74% Public Companies and
Individual Investors